Exon Publications publishes peer-reviewed, open access review articles, monographs, and books specializing in the biomedical and health sciences. Explore our Catalog for a comprehensive list of published works. To publish your manuscript with us, please click on the link below.

                                                                                Explore Publishing Options 


As per the 2023 Google Scholar Metrics, released on July 19, 2023, Exon Publications has an impressive h-5 index of 19 and an h-5 median of 33. Without much ado, it simply means that if you are aiming for enhanced visibility and recognition of your hard work, choose Exon Publications.



Our edited books are indexed in NCBI/NIH/NLM Bookshelf, PubMed, Europe PubMed Central, Directory of Open Access Books (DOAB), and Google Scholar. 

Directory of Open Access BooksExon PubMed indexingExon Europe PMC indexing

Exon Publications is a member of the Open Access Scholarly Publishing Association, and CrossRef.



PET Agents for Primary Brain Tumor Imaging

The role of molecular imaging with positron emission tomography (PET) for diagnosis, treatment planning and post-treatment monitoring of brain tumors has grown substantially in the last decades. In the last 25 years, almost 50 different PET agents have been developed and tested in human clinical studies. While some of these PET agents are yet to make their way into clinical practice, others have already established pivotal roles in brain tumor imaging. Although all these agents share an affinity for brain tumor cells, they target different tumor-altered molecular pathways within these cells: some agents are taken up by the cell through overexpressed transporters and become trapped, altered, or incorporated into upregulated metabolic pathways, while other agents bind to overexpressed receptors or to cells present in the tumor microenvironment. In this monograph, we explore the major genetic and molecular changes characteristic of brain tumors, how they are used by PET agents to gain access to tumor cells and their environment, and how this translates to uptake in clinical practice. Gaining insight in these processes is essential for correct image interpretation and helps to understand why some agents are more successful than others.

Published: 2023-12-21

PET Agents for Primary Brain Tumor Imaging

Anja van der Kolk, MD, PhD, Dylan Henssen, MD, PhD, Harry W Schroeder III, MD, PhD, Lance T Hall, MD
View All Books